ArticleProceedings (Baylor University. Medical Center)2026
Endovascular management of symptomatic May-Thurner syndrome: real-world procedural approaches and outcomes.
Article in Proceedings (Baylor University. Medical Center), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMay-Thurner syndrome (MTS) is characterized by extrinsic venous compression by the arterial system in ilio-caval territory leading to venous stasis, a predisposition to deep vein thrombosis (DVT), and edema. Endovascular interventions have become the cornerstone of treatment for patients with symptomatic MTS. We evaluated the safety and outcomes of patients with MTS who underwent endovascular management at our tertiary care center.
methodsWe included 19 patients with symptomatic MTS who underwent vascular interventional procedures. Data were extracted from electronic medical records. The study outcomes included procedural safety, the Villalta score, and venous patency during follow-up.
resultsAll patients had left-sided DVT and 47.4% had predisposing factors. Seven patients underwent a single-stage procedure with mechanical thrombectomy with or without thrombolysis, and six received stents. Twelve underwent a two-stage procedure, including initial thrombectomy with or without thrombolysis, continuous infusion thrombolysis for several hours in between, and repeat thrombectomy with or without thrombolysis, angioplasty, and stenting at the end. The mean Villalta score was 0.8 ± 1.6, with 94% venous patency at a median follow-up of 6 months.
conclusionEndovascular interventions achieved excellent short-term outcomes, including high procedural success, substantial symptom resolution, and near-complete venous patency. These findings underscore the importance of prompt diagnosis and appropriate management of patients with symptomatic MTS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.